These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 601957)

  • 21. [Modification of platelet aggregation in patients with diabetic retinopathy].
    Regnault F; Kern P
    C R Seances Soc Biol Fil; 1971; 165(4):769-74. PubMed ID: 4259483
    [No Abstract]   [Full Text] [Related]  

  • 22. Platelet behaviour in diabetic retinopathy.
    Youssef L; Afifi N; Shalash B; Hassanein AA
    Bull Ophthalmol Soc Egypt; 1978; 71(75):93-102. PubMed ID: 549737
    [No Abstract]   [Full Text] [Related]  

  • 23. [The role of erythrocyte aggregation in the pathogenesis of microcirculatory changes in the retina of patients with diabetes mellitus].
    Beliaeva IM
    Vestn Oftalmol; 1988; 104(1):66-71. PubMed ID: 3285571
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hemorheologic findings in diabetes and their clinical relevance].
    Volger E
    Wien Med Wochenschr; 1986; 136 Spec No():5-10. PubMed ID: 3825172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathogenesis of diabetic retinopathy--observation on platelet adhesiveness and aggregation].
    Zhu ZR
    Zhonghua Yan Ke Za Zhi; 1984 Jan; 20(1):38-40. PubMed ID: 6434270
    [No Abstract]   [Full Text] [Related]  

  • 26. Activity of Daflon 500 mg on the hemorheological disorders in diabetes.
    Lacombe C; Lelievre JC; Bucherer C; Grimaldi A
    Int Angiol; 1989; 8(4 Suppl):45-8. PubMed ID: 2632648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy.
    Yamaguchi M; Nakamura N; Nakano K; Kitagawa Y; Shigeta H; Hasegawa G; Ienaga K; Nakamura K; Nakazawa Y; Fukui I; Obayashi H; Kondo M
    Diabet Med; 1998 Jun; 15(6):458-62. PubMed ID: 9632118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood viscosity factors in severe nondiabetic and diabetic retinopathy.
    Dintenfass L
    Biorheology; 1977; 14(4):151-7. PubMed ID: 912043
    [No Abstract]   [Full Text] [Related]  

  • 29. [Functional platelet evaluations in diabetic retinopathy patients].
    Grange JD; Thouverez JP
    Bull Soc Ophtalmol Fr; 1978 Jan; 78(1):37-40. PubMed ID: 729150
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased protein carbonylation of red blood cell membrane in diabetic retinopathy.
    Margetis PI; Antonelou MH; Petropoulos IK; Margaritis LH; Papassideri IS
    Exp Mol Pathol; 2009 Aug; 87(1):76-82. PubMed ID: 19379730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythrocyte membrane anionic content and urinary glycosaminoglycan excretion in type 1 diabetes: association with retinopathy.
    Yenice O; Kazokoğlu H; Ozcan E; Yüksel M; Adigüzel G; Haklar G; Yavuz DG
    Curr Eye Res; 2006 Nov; 31(11):975-81. PubMed ID: 17114123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A study of Na(+)-K(+)-ATP ase activity in erythrocyte membrane from diabetic retinopathy patients].
    He J; Qiu Y; Zhou X
    Zhonghua Yan Ke Za Zhi; 1998 Nov; 34(6):421-3. PubMed ID: 11877243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does increased platelet aggregation have a prognostic value in the deterioration of background diabetic retinopathy? The Damad Study Group.
    Plu G; Lecrubier C; Scarabin PY; Baudoin C; Samama M
    Thromb Haemost; 1990 Oct; 64(2):202-5. PubMed ID: 2270529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preliminary findings on 2 groups of diabetics with regard to platelet aggregation in relation to retinopathy and ultimate relation to antidiabetic therapy].
    Cavaliere R; Giangrandi E; Innocenti M; Parisi R
    Minerva Med; 1978 Jun; 69(28):1923-8. PubMed ID: 662185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Platelet aggregation in diabetes mellitus in relation to diabetic retinopathy].
    Miralles García JM; Pablo Dávila F; Sánchez Martín S; Alberca Silva I
    Rev Clin Esp; 1980 May; 157(3):183-85. PubMed ID: 7403595
    [No Abstract]   [Full Text] [Related]  

  • 36. [Endotelon. Diabetic retinopathy and hemorheology (preliminary study)].
    Soyeux A; Seguin JP; Le Devehat C; Bertrand A
    Bull Soc Ophtalmol Fr; 1987 Dec; 87(12):1441-4. PubMed ID: 3453307
    [No Abstract]   [Full Text] [Related]  

  • 37. Blood antioxidant parameters in patients with diabetic retinopathy.
    Siemianowicz K; Gminski J; Telega A; Wójcik A; Posielezna B; Grabowska-Bochenek R; Francuz T
    Int J Mol Med; 2004 Sep; 14(3):433-7. PubMed ID: 15289896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of platelet kinetics and some coagulation parameters in diabetic retinopathy.
    Sacchi S; Curci G; Peduzzi M; Barbieri U; Piccinini L
    Panminerva Med; 1981; 23(1):21-4. PubMed ID: 6793985
    [No Abstract]   [Full Text] [Related]  

  • 39. [Significance of serotonin in the pathogenesis of diabetic retinopathy and central chorioretinal dystrophy].
    Mukha AI; Korzenkova LV; Fedorova NV; Syromiatnikova ED
    Vestn Oftalmol; 2002; 118(4):31-3. PubMed ID: 12371320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex hormones and diabetic retinopathy.
    Chaurasia RK; Singh R; Agrawal JK; Maurya OP
    Ann Ophthalmol; 1993 Jun; 25(6):227-30. PubMed ID: 8338319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.